MY100022A - Medical composition for external application - Google Patents

Medical composition for external application

Info

Publication number
MY100022A
MY100022A MYPI87000383A MYPI19870383A MY100022A MY 100022 A MY100022 A MY 100022A MY PI87000383 A MYPI87000383 A MY PI87000383A MY PI19870383 A MYPI19870383 A MY PI19870383A MY 100022 A MY100022 A MY 100022A
Authority
MY
Malaysia
Prior art keywords
independently represent
external application
medical composition
formula
hydrocarbon group
Prior art date
Application number
MYPI87000383A
Other languages
English (en)
Inventor
Kamiya Tetsuro
Tsujii Kaoru
Hara Kenji
Takahashi Hiromichi
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Publication of MY100022A publication Critical patent/MY100022A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MYPI87000383A 1984-10-11 1987-03-26 Medical composition for external application MY100022A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59213152A JPS6191137A (ja) 1984-10-11 1984-10-11 外用薬剤組成物

Publications (1)

Publication Number Publication Date
MY100022A true MY100022A (en) 1989-04-20

Family

ID=16634426

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI87000383A MY100022A (en) 1984-10-11 1987-03-26 Medical composition for external application

Country Status (7)

Country Link
US (1) US4686211A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0179277B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS6191137A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3565937D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES8701683A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK33691A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY100022A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01151516A (ja) * 1987-12-08 1989-06-14 Shionogi & Co Ltd ビタミンｅ配合外用剤
GB8828013D0 (en) * 1988-12-01 1989-01-05 Unilever Plc Topical composition
GB8828014D0 (en) * 1988-12-01 1989-01-05 Unilever Plc Topical composition
GB8828018D0 (en) * 1988-12-01 1989-01-05 Unilever Plc Topical composition
GB8828020D0 (en) * 1988-12-01 1989-01-05 Unilever Plc Topical composition
GB8828017D0 (en) * 1988-12-01 1989-01-05 Unilever Plc Topical composition
US4906454A (en) * 1989-02-23 1990-03-06 The Procter & Gamble Company Deodorant compositions containing specific piroctone salts and perfumes
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
GB9003199D0 (en) * 1990-02-13 1990-04-11 Unilever Plc Topical composition
US5565207A (en) * 1990-09-19 1996-10-15 Pola Kasei Kogyo Kabushiki Kaisha Scalp moisturizer and external skin preparation
GB9101986D0 (en) * 1991-01-30 1991-03-13 Smith & Nephew Pharmaceutical compositions
US5409911A (en) * 1992-09-11 1995-04-25 Merck & Co., Inc. Prostaglandin analog for treating osteoporosis
TW251302B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1992-12-28 1995-07-11 Kao Corp
US5665742A (en) * 1994-05-31 1997-09-09 Kao Corporation Bath medicine composition and its use in inhibiting the generation of body odor
US6239172B1 (en) * 1997-04-10 2001-05-29 Nitrosystems, Inc. Formulations for treating disease and methods of using same
US20110196039A9 (en) * 1994-10-05 2011-08-11 Kaesemeyer Wayne H Controlled release arginine formulations
US5543430A (en) * 1994-10-05 1996-08-06 Kaesemeyer; W. H. Method and formulation of stimulating nitric oxide synthesis
US5968983A (en) * 1994-10-05 1999-10-19 Nitrosystems, Inc Method and formulation for treating vascular disease
US5560913A (en) * 1995-01-27 1996-10-01 The Procter & Gamble Company Pharmaceutical compositions
US6605751B1 (en) * 1997-11-14 2003-08-12 Acrymed Silver-containing compositions, devices and methods for making
US6426093B1 (en) * 1998-02-09 2002-07-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem Synergistic biocidal activity if ternary complexes of negatively-charged biocides (component A), transition metal ions (component B), and neutral chelators (component C)
US5972920A (en) * 1998-02-12 1999-10-26 Dermalogix Partners, Inc. Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
US6121253A (en) * 1998-11-20 2000-09-19 Merck Frosst Canada & Co. Prostaglandin conjugates for treating or preventing bone disease
US6254294B1 (en) * 1999-08-09 2001-07-03 Sigrid G. Muhar Pharmaceutical kit
FR2799369B1 (fr) * 1999-10-08 2001-12-21 Oreal Association d'escine et de sulfate de dextran et son utilisation
ATE327779T1 (de) 1999-12-30 2006-06-15 Acrymed Methode und zusammensetzungen für verbesserte abgabevorrichtungen
US7758888B2 (en) 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
MXPA03003585A (es) * 2000-11-14 2003-07-14 Vital Health Sciences Pty Ltd Complejos de derivados de fosfato.
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
EP1254909A1 (de) * 2001-04-30 2002-11-06 Cognis Iberia, S.L. Phosphorsäureester
WO2003011303A1 (en) * 2001-07-27 2003-02-13 Vital Health Sciences Pty Ltd Dermal therapy using phosphate derivatives of electron transfer agents
US20050089495A1 (en) * 2001-12-13 2005-04-28 West Simon M. Transdermal transport of compounds
US6833139B1 (en) * 2002-01-09 2004-12-21 Ferndale Laboratories, Inc. Composition and method for the treatment of anorectal disorders
CN1678277B (zh) * 2002-07-29 2010-05-05 艾克里麦德公司 治疗皮肤病的方法和组合物
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
EP1589964B1 (en) * 2003-01-17 2011-11-23 Vital Health Sciences Pty Ltd. Compounds having anti-proliferative properties
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
NZ549567A (en) * 2004-03-03 2009-10-30 Vital Health Sciences Pty Ltd Formulations comprising a tocopheryl phosphate tertiary amine alkaloid complex
US20050282870A1 (en) * 2004-06-16 2005-12-22 Carter Stephen G Peripherally-acting vasodilators
NZ552928A (en) * 2004-07-30 2011-05-27 Acrymed Inc Antimicrobial silver compositions
US8361553B2 (en) 2004-07-30 2013-01-29 Kimberly-Clark Worldwide, Inc. Methods and compositions for metal nanoparticle treated surfaces
US10251392B2 (en) * 2004-07-30 2019-04-09 Avent, Inc. Antimicrobial devices and compositions
US9289378B2 (en) * 2004-09-20 2016-03-22 Avent, Inc. Antimicrobial amorphous compositions
EP1858508A4 (en) * 2005-03-03 2009-01-07 Vital Health Sciences Pty Ltd COMPOUNDS HAVING ANTICANCER PROPERTIES
EP2548581A3 (en) * 2005-06-17 2013-02-20 Vital Health Sciences Pty Ltd. A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
CA2617681C (en) 2005-08-02 2015-02-03 Sol-Gel Technologies Ltd. Metal oxide coating of water insoluble ingredients
BRPI0621081A2 (pt) * 2005-12-23 2011-11-29 Vital Health Sciences Pty Ltd método de modulação de uma ou mais citocinas imuno-reguladoras, uso de um ou mais derivados de fosfato de um ou mais hidróxi cromanos ou complexos dos mesmos, método de inibição de uma resposta inflamatória e/ou de estimulação de uma resposta anti-inflamatória, método de tratamento e/ou de profilaxia de distúbios imunológicos, distúrbios inflamatórios e/ou distúrbios proliferativos celulares, agente imuno-modulador, agente anti-inflamatório ou agente anti-cáncer e um ou mais derivado de fosfato de um ou mais hidróxi cromanos ou complexos dos mesmos
EP2015722B1 (en) * 2006-04-28 2016-11-16 Avent, Inc. Antimicrobial site dressings
JP2010517996A (ja) 2007-02-01 2010-05-27 ソル − ゲル テクノロジーズ リミテッド 過酸化物及びレチノイドを含む局所適用用組成物
CN101754677B (zh) * 2007-02-01 2013-10-02 索尔-格尔科技有限公司 制备包含金属氧化物涂层的颗粒的方法和具有金属氧化物涂层的颗粒
JP2010235523A (ja) * 2009-03-31 2010-10-21 Kao Corp 水性毛髪洗浄剤
ES2999020T3 (en) 2010-02-05 2025-02-24 Phosphagenics Ltd Carrier comprising non-neutralised tocopheryl phosphate
RU2553350C2 (ru) 2010-03-30 2015-06-10 Фосфейдженикс Лимитед Трансдермальные пластыри
EP2685992A4 (en) 2011-03-15 2014-09-10 Phosphagenics Ltd AMINOCHINOLINE AS A KINASEHEMMER
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
CA3007587C (en) 2015-12-09 2023-12-05 Phosphagenics Limited Pharmaceutical formulation
EP3558903B1 (en) 2016-12-21 2024-07-03 Avecho Biotechnology Limited Process for phosphorylating a complex alcohol
JP2020527140A (ja) 2017-07-12 2020-09-03 ソル − ゲル テクノロジーズ リミテッド カプセル化トレチノインを含む組成物
JP2019043853A (ja) * 2017-08-30 2019-03-22 旭化成株式会社 経皮吸収促進剤、経皮吸収促進助剤、及び経皮製剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4046886A (en) * 1975-01-17 1977-09-06 The Procter & Gamble Company Dermatological compositions
US4130667A (en) * 1976-01-12 1978-12-19 The Procter & Gamble Company Dermatological compositions

Also Published As

Publication number Publication date
ES8701683A1 (es) 1986-12-01
EP0179277A1 (en) 1986-04-30
HK33691A (en) 1991-05-10
US4686211A (en) 1987-08-11
JPH0469129B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1992-11-05
JPS6191137A (ja) 1986-05-09
ES547738A0 (es) 1986-12-01
DE3565937D1 (en) 1988-12-08
EP0179277B1 (en) 1988-11-02

Similar Documents

Publication Publication Date Title
MY100022A (en) Medical composition for external application
HUP9600448A2 (hu) Naftilvegyületek, e vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra, intermedierjeik és alkalmazásuk
DE10199023I2 (de) Benzoenaphthalinderivate Verfahren zu deren Herstellung und ihre Verwendung in Pharmazie und Kosmetik
DE69116135D1 (de) Verwendung von alpha-tocopherolphosphat oder eines derivates davon zur herstellung kosmetischer dermatologischer oder pharmazeutischer präparate
NO170280C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfamatderivater
MD1900B2 (en) Aerosolic pharmaceutical composition and method of treatment of respiratory affections
GB8328111D0 (en) Chemical compounds
GB8328073D0 (en) Chemical compounds
EP0034473A3 (en) Substituted imidazoles, their preparation, pharmaceutical compositions containing the same and their use in therapy
AUPO111096A0 (en) New compound
DE3476847D1 (en) A remedial or prophylactic agent for the treatment of seizures
ES8400427A1 (es) Un procedimiento para la preparacion de nuevos derivados de 2-piperazino pirimidina.
HK17993A (en) Tetrahydrofuran derivatives
ES476645A1 (es) Procedimiento para la obtencion de derivados aminados de pi-razol (1,5-a)s troazina.
ES472085A1 (es) Un procedimiento para la preparacion de una composicion te- rapeutica para el tratamiento de enfermedades alergicas.
HUT45250A (en) Process for producing 5-substituted octahydro-indolysin derivatives and pharmaceutical compositions containing them as active components
HUT41025A (en) Process for preparing octahydro-indolizine derivatives and pharmaceutical compositions containing such compounds as active ingredients
ES8100249A1 (es) Un metodo para la preparacion de un compuesto de acido hi- droxamico
AU558461B2 (en) Carbamyloxybenzhyrol derivatives
AU560542B2 (en) Pyridazine derivatives which have c.n.s. activity
JO1499B1 (en) New Derivatives of 16,17-Acetal Acid Replaced by Brennan 21-Uic
KR950702412A (ko) 항 hiv제
EP0144441A4 (en) BLOOD PRESSURE REGULATING AGENCY.
GR3036868T3 (en) Amino alcohol derivatives, methods of producing said derivatives and medicaments containing them
ATE89160T1 (de) Topische zubereitung zur behandlung von alopecie.